UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Kaposi's Sarcoma Studies

Current treatments for Kaposi's sarcoma (KS) often do not cure the disease and better treatments are needed.  Investigators are studying new drugs to better understand their side effects and to examine if they can be used to help stop HIV from progressing and to help stop the growth of cancer cells.


The UCLA CARE Center has studies available that examine new treatments for KS:   

AMC 063
Study examining the tolerability and best dose of bortezomib for treating patients with relapsed or refractory AIDS-related Kaposi's sarcoma. Bortezomib may stop the growth of tumor cells by blocking some of the enzymes needed for tumor growth.


For more information about the UCLA CARE Center's clinical trials and research studies, please contact:
Phone:  (310) 557-9062
Email:  CAREOutreach@mednet.ucla.edu